1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61E65AED6721234DA852581B8003AAEEF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/1E65AED6721234DA852581B8003AAEEF!OpenDocument
18
19OpenDocument
203.94.202.88
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Digital Marketing

Forging Top-Tier Biopharma Digital Strategy: Benchmarks on Service Structure, Resources & Operations

ID: 5481


Features:

9 Info Graphics

28 Data Graphics

300+ Metrics

2 Narratives


Pages/Slides: 45


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Forging Top-Tier Biopharma Digital Strategy: Benchmarks on Service Structure, Resources & Operations”

STUDY OVERVIEW


As digital technologies continue to evolve, pharmaceutical and medical device companies must continuously adapt their digital marketing approaches to effectively reach a varied set of customers. Therefore, organizations must use their internal structure and supporting functions to enhance the effectiveness of their digital marketing programs.

Best Practices, LLC undertook this research to establish new benchmarks and provide critical insights into how leading pharmaceutical and medical device firms are putting their digital strategies into action. In particular, this study delivers benchmarks around key performance areas including digital strategy, staffing & investment, vendor management & service alignment, field sales support, and cost management. Digital leaders can use this study to compare their digital programs with leading peer organizations.

KEY TOPICS

  • Digital Marketing Service Structure
  • Digital Marketing Budget and Staffing Allocation
  • Digital Tactics for Boosting Sales Force Effectiveness
  • Service Management Excellence
  • Innovative Vendor Management
  • Digital Tools and Tactics to Reduce Overall Cost

KEY METRICS

  • Approximately what percentage of your organization's total marketing budget is devoted specifically to Digital Marketing activities and programs?
  • What is your organization’s total FTE staffing investment for all of digital marketing?
  • How effective are each of the listed approaches for raising sales force effectiveness?
  • Which group within your organization is primarily responsible for each core digital activity listed below?
  • How many vendors and agencies does your digital marketing group currently partner with across all of the brands you support?
  • How successful has your organization been in using various digital tools and tactics to reduce overall costs?

SAMPLE KEY FINDINGS

  • By 2018, the average percentage of total marketing dollars spent on digital programs will rise to 23%, up significantly from the current average of 18%.
  • Companies are using digital tools and tactics to reduce overall marketing and education costs. Effective tactics include the use of virtual meetings and cloud-based networks.

METHODOLOGY


Best Practices, LLC engaged 21 digital, multichannel marketing and other commercial leaders from 19 leading healthcare organizations through a benchmarking survey. Close to two-thirds of the participants serve at director level or above.


Industries Profiled:
Diagnostic; Biopharmaceutical; Pharmaceutical; Manufacturing; Biotech; Consumer Products; Medical Device; Clinical Research; Health Care; Consulting; Laboratories


Companies Profiled:
Alere; Alnylam Pharmaceuticals; AstraZeneca; Bayer; Boehringer Ingelheim; CMIC; Daiichi Sankyo; EMD Serono; Medtronic; Merck; MSD; Novartis; Precision For Value; Roche; Salix Pharmaceutical; Sanofi; Takeda Pharmaceuticals; The Himalaya Drug Company; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.